Table 1. Baseline characteristics Study,... | American Society of Hematology

Table 1.

Baseline characteristics

Study, year	Patients, no.	Mean or median follow-up, mo	Study design	Consecutive enrollment	Lost at follow-up, no.
Appenzeller et al,²⁸ 2005	24	44	Retrospective	Yes	0
Stolz et al,^9,10 2005	79	31	Prospective, retrospective	Yes	2
Ferro et al,^1,27 2005	624	16	Prospective	Yes	8
Favrole et al,¹¹ 2004	28	3	Retrospective	No	0
Cakmak et al,¹⁴ 2003	16	3	Prospective	Yes	0
Breteau et al,²¹ 2003	55	36	Retrospective	Yes	0
Mehraein et al,¹⁵ 2003	39	123	Retrospective	Yes	NA
Baumgartner et al,¹² 2003	33	12	Prospective	Yes	0
Buccino et al,¹³ 2002	36	42	Retrospective	No	1
Ferro et al,¹⁶ 2002	142	22	Prospective, retrospective	Yes	7
Strupp et al,¹⁷ 2002	40	145	Retrospective	No	NA
Fink and McAuley,¹⁸ 2001	25	10.8	Retrospective	No	0
Mak et al,²⁰ 2001	13	5-36*	Retrospective	Yes	0
de Bruijn et al,^4,19 2001	59	18.5	Retrospective	Yes	4
Lamy et al,²² 2000	68	60	Prospective	Yes	NA
Lleo et al,²³ 1999	17	26.33	Retrospective	No	0
Preter et al,²⁴ 1996	110	77.8	Retrospective	Yes	25
Rondepierre et al,²⁵ 1995	18	31	Prospective	Yes	0
Bienfait et al,²⁶ 1995	62	3	Retrospective	No	0

Study, year	Patients, no.	Mean or median follow-up, mo	Study design	Consecutive enrollment	Lost at follow-up, no.
Appenzeller et al,²⁸ 2005	24	44	Retrospective	Yes	0
Stolz et al,^9,10 2005	79	31	Prospective, retrospective	Yes	2
Ferro et al,^1,27 2005	624	16	Prospective	Yes	8
Favrole et al,¹¹ 2004	28	3	Retrospective	No	0
Cakmak et al,¹⁴ 2003	16	3	Prospective	Yes	0
Breteau et al,²¹ 2003	55	36	Retrospective	Yes	0
Mehraein et al,¹⁵ 2003	39	123	Retrospective	Yes	NA
Baumgartner et al,¹² 2003	33	12	Prospective	Yes	0
Buccino et al,¹³ 2002	36	42	Retrospective	No	1
Ferro et al,¹⁶ 2002	142	22	Prospective, retrospective	Yes	7
Strupp et al,¹⁷ 2002	40	145	Retrospective	No	NA
Fink and McAuley,¹⁸ 2001	25	10.8	Retrospective	No	0
Mak et al,²⁰ 2001	13	5-36*	Retrospective	Yes	0
de Bruijn et al,^4,19 2001	59	18.5	Retrospective	Yes	4
Lamy et al,²² 2000	68	60	Prospective	Yes	NA
Lleo et al,²³ 1999	17	26.33	Retrospective	No	0
Preter et al,²⁴ 1996	110	77.8	Retrospective	Yes	25
Rondepierre et al,²⁵ 1995	18	31	Prospective	Yes	0
Bienfait et al,²⁶ 1995	62	3	Retrospective	No	0

NA indicates not assessed.

Range.